CJ 40012Alternative Names: CJ40012
Latest Information Update: 23 Dec 2015
At a glance
- Originator CJ HealthCare
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Eye disorders
Most Recent Events
- 23 Dec 2015 Early research in Eye disorders (retinopathy) in South Korea (unspecified route) (CJ Healthcare pipeline, December 2015)